INSR and Hyperglycemia: The indirect impact on insulin receptor signaling might also play a role, as IGF-1R inhibitors block the insulin receptor, preventing insulin from binding to its receptor, thereby inhibiting cellular glucose uptake and leading to hyperglycemia (45).